Literature DB >> 3341363

Asymmetric stratification. An outline for an efficient method for controlling confounding in cohort studies.

E F Cook1, L Goldman.   

Abstract

Confounding is usually controlled by either cross-stratification or multivariate modeling. The first approach is simple and intuitive, but it is not practical for controlling many factors. The second approach, although less intuitive, may provide a more efficient means for controlling many confounders, but its ability to control confounding depends on the appropriateness of the chosen model. Hybrid methods based on a multivariate confounder score or a propensity score combine the favorable characteristics of both methods and may be better suited for controlling many confounders. However, the resulting strata are defined by subranges of a multivariate model, and, therefore, may possess little intrinsic meaning. The authors propose the principle of asymmetric stratification to control efficiently a number of confounders in cohort studies while retaining the intuitive appeal and general framework of cross-stratification. The proposed method resembles a propensity score analysis but does not use a multivariate model to define the strata. Instead, strata are defined by the categories of only a subset of the original potential confounders. The authors also demonstrate how our proposed method can be implemented by an application of classification and regression trees (CART) (recursive partitioning), as outlined by Breiman et al. (Classification and Regression Trees. Belmont, CA: Wadsworth, 1984). Computer simulations and an actual example suggest that the proposed method is a potentially simpler alternative to the standard propensity score analysis. Specific recommendations on how the proposed method can be improved are also presented.

Entities:  

Mesh:

Year:  1988        PMID: 3341363     DOI: 10.1093/oxfordjournals.aje.a114838

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

1.  Expanding the scope of risk assessment: methods of studying differential vulnerability and susceptibility.

Authors:  Joel Schwartz; David Bellinger; Thomas Glass
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

Review 2.  Indications for propensity scores and review of their use in pharmacoepidemiology.

Authors:  Robert J Glynn; Sebastian Schneeweiss; Til Stürmer
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

3.  High volume and outcome after liver resection: surgeon or center?

Authors:  Robert W Eppsteiner; Nicholas G Csikesz; Jessica P Simons; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

4.  Surgeon volume metrics in laparoscopic cholecystectomy.

Authors:  Nicholas G Csikesz; Anand Singla; Melissa M Murphy; Jennifer F Tseng; Shimul A Shah
Journal:  Dig Dis Sci       Date:  2009-11-13       Impact factor: 3.199

5.  Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users.

Authors:  Viviane Dias Lima; Bohdan Nosyk; Evan Wood; Tsubasa Kozai; Wendy Zhang; Keith Chan; Julio S G Montaner
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

6.  Propensity score estimation: neural networks, support vector machines, decision trees (CART), and meta-classifiers as alternatives to logistic regression.

Authors:  Daniel Westreich; Justin Lessler; Michele Jonsson Funk
Journal:  J Clin Epidemiol       Date:  2010-08       Impact factor: 6.437

7.  Association between common iron store markers and hemoglobin in children with chronic kidney disease.

Authors:  Meredith A Atkinson; Christopher B Pierce; Jeffrey J Fadrowski; Nadine M Benador; Colin T White; Martin A Turman; Cynthia G Pan; Alison G Abraham; Bradley A Warady; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2012-07-27       Impact factor: 3.714

8.  Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.

Authors:  Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong-van den Berg; Ron T Gansevoort
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

9.  A methodological framework for drug development in rare diseases.

Authors:  Patrice Nony; Polina Kurbatova; Agathe Bajard; Salma Malik; Charlotte Castellan; Sylvie Chabaud; Vitaly Volpert; Nathalie Eymard; Behrouz Kassai; Catherine Cornu
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

10.  Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases.

Authors:  Zhiyu Wang; Xiaoting Wen; Yaohong Lu; Yang Yao; Hui Zhao
Journal:  Oncotarget       Date:  2016-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.